BioCentury | Jan 21, 2013
Clinical News

Aptima Trichomonas vaginalis assay regulatory update

...FDA approved Hologic's Aptima Trichomonas vaginalis assay for use on its Panther instrument system to detect T. vaginalis infection...
...Gen-Probe Inc. last year (see BioCentury, Aug. 6, 2012). Hologic Inc. (NASDAQ:HOLX), Bedford, Mass. Product: Aptima Trichomonas vaginalis assay...
BioCentury | Apr 25, 2011
Clinical News

Aptima Trichomonas vaginalis assay regulatory update

...FDA granted 510(k) clearance for Gen-Probe's Aptima Trichomonas vaginalis assay to detect T. vaginalis infection. The amplified nucleic acid...
...and has CE Mark approval in the EU. Gen-Probe Inc. (NASDAQ:GPRO), San Diego, Calif. Product: Aptima Trichomonas vaginalis assay...
BioCentury | Oct 11, 2010
Clinical News

Aptima Trichomonas vaginalis assay regulatory update

...Gen-Probe submitted a 510(k) application to FDA for its Aptima Trichomonas vaginalis assay to detect T. vaginalis infection. The...
...approval in the EU (see BioCentury, July 5). Gen-Probe Inc. (NASDAQ:GPRO), San Diego, Calif. Product: Aptima Trichomonas vaginalis assay...
BioCentury | Jul 5, 2010
Finance

2H10 milestones

...treatment for metastatic breast cancer FDA panel meeting; PDUFA date 7/20/10; 9/17/10 Gen-Probe Inc. (NASDAQ:GPRO) Aptima Trichomonas vaginalis assay...
BioCentury | Jul 5, 2010
Clinical News

Aptima Trichomonas vaginalis assay regulatory update

...U.S. approval of the assay later this year. Gen-Probe Inc. (NASDAQ:GPRO), San Diego, Calif. Product: Aptima Trichomonas vaginalis assay...
BioCentury | Aug 24, 2009
Clinical News

Aptima Trichomonas vaginalis assay: Pivotal trial started

...to evaluate its Aptima Trichomonas vaginalis assay in about 800 women. Gen-Probe Inc. (NASDAQ:GPRO), San Diego, Calif. Product: Aptima Trichomonas vaginalis assay...
Items per page:
1 - 6 of 6